Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.3M
-21.8% from 2023
Prescriptions
2,613
$480.35 per claim
Patients
755
356 prescribers
Total spending, 2024
$1.2M
$1,658.83 per patient
Medicare prescription drug plans paid $1.3M for Docetaxel in 2024, for 2,613 prescriptions and refills to 755 patients (down 21.8% from 2023). The average cost per claim was $480.35.
New York had the highest Medicare cost for Docetaxel in 2024: $438K for 682 claims, followed by California ($255K).
Jahan Aghalar, medical oncology in Commack, NY, had the highest Medicare cost for Docetaxel in 2024: 69 claims costing $38K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jahan Aghalar Commack, NY | Medical Oncology | 69 | 18 | $38K |
| Michael H Nguyen Torrance, CA | Hematology-Oncology | 33 | Under 11 | $32K |
| Ratesh Khillan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 236 | 1,848 | 497 | $1.5M |
| 2023 | 313 | 2,320 | 639 | $1.6M |
| 2024 | 356 | 2,613 | 755 | $1.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 23 |
| Under 11 |
| $29K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 38 | Under 11 | $26K |
| Raj Satkunasivam Houston, TX | Urology | 23 | 16 | $25K |
| Alex Wu Brooklyn, NY | Hematology-Oncology | 19 | Under 11 | $25K |
| Thomas J Katta Orlando, FL | Hematology-Oncology | 18 | Under 11 | $25K |
| Aasim S Sehbai Anniston, AL | Medical Oncology | 18 | Under 11 | $22K |
| Eric M Cheung Lakewood, CA | Hematology-Oncology | 12 | Under 11 | $21K |
| Zili He X Flushing, NY | Hematology-Oncology | 23 | Under 11 | $21K |
| Benjamin P Negin Vineland, NJ | Hematology-Oncology | 14 | Under 11 | $21K |
| Dirk C Davidson Crossville, TN | Medical Oncology | 24 | Under 11 | $19K |
| Richards Afonja Clifton, NJ | Hematology-Oncology | 11 | Under 11 | $17K |
| Astrid Belalcazar Montgomery, AL | Hematology-Oncology | 25 | Under 11 | $17K |
| Michael S Chung Torrance, CA | Hematology-Oncology | 22 | Under 11 | $16K |
| Hitendra M Rambhia Brooklyn, NY | Hematology-Oncology | 14 | Under 11 | $16K |
| Javier Ruiz New Windsor, NY | Hematology-Oncology | 18 | Under 11 | $16K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 25 | Under 11 | $16K |
| Trina Poretta Voorhees, NJ | Hematology-Oncology | 22 | Under 11 | $15K |
| Nino Aleksidze Montgomery, AL | Hematology-Oncology | 12 | Under 11 | $14K |
| Delfino M Crescenzo Howard Beach, NY | Hematology-Oncology | 11 | Under 11 | $13K |
| Samir C Patel Newburgh, NY | Hematology-Oncology | 19 | Under 11 | $13K |
| Eugenio G Galindo McAllen, TX | Hematology-Oncology | 48 | Under 11 | $11K |
| Joseph My Stuart, FL | Hematology-Oncology | 23 | Under 11 | $11K |
| Rahul R Naik Los Angeles, CA | Hematology-Oncology | 12 | Under 11 | $10K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Sandoz SDZ.SW | 313 | $364K |
| Winthrop US | 750 | $315K |
| Ingenus Pharmac | 150 | $148K |
| Hospira/Pfizer | 533 | $147K |
| Mylan Instituti VTRS | 192 | $90K |
| Alembic Pharmac | 67 | $82K |
| Sagent Pharmace | 377 | $44K |
| Actavis/Teva TEVA | 41 | $22K |
| Meitheal Pharma | 76 | $16K |
| Amneal Pharmace AMRX | 50 | $5,362 |
| West-Ward/Hikma HIK.L | 21 | $5,198 |
| Hosp/Pfiz-Premi | 17 | $5,194 |
| Eugia US LLC | 11 | $2,000 |